AdvanSix Appoints Jeffrey Bird to Board of Directors Effective January 2026

Written by Emily J. Thompson, Senior Investment Analyst

Source: Businesswire

Updated: Dec 22 2025

0mins

ASIX+3.7%

Should l Buy ASIX?

Source: Businesswire

Board Expansion: AdvanSix announced the appointment of Jeffrey J. Bird as an independent director effective January 1, 2026, increasing the board to ten members, with nine being independent, thereby enhancing corporate governance.
Rich Industry Experience: Currently serving as Interim President and COO of Envent Corporation, Bird brings extensive financial and operational leadership experience in complex industries, which will provide strategic oversight to the board.
Audit and Safety Committees: Bird will serve on the Audit Committee and the Health, Safety, and Environmental Committee of the board, further enhancing the company's governance capabilities in these critical areas.
Commitment to Long-term Growth: Bird's appointment reflects AdvanSix's strong commitment to enhancing the strategic vision of the board and driving long-term growth and shareholder value, aimed at supporting safe, stable, and sustainable operations.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy ASIX?" and start using high-conviction signals backed by rigorous historical data.

ASIX

$18.5+Infinity%1D

Analyst Views on ASIX

About ASIX

AdvanSix Inc. is a diversified chemistry company that produces essential materials for its customers in a variety of end markets and applications, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Its product lines include nylon solutions, plant nutrients, and chemical intermediates. It sells its Nylon 6 resin globally, under the Aegis brand name. It markets and sells ammonium sulfate to North American and South American distributors, farm cooperatives and retailers to fertilize crops. It also manufactures sulfuric acid, ammonia and carbon dioxide. It manufactures, markets and sells a number of chemical intermediate products. Its other intermediate chemicals include phenol, alpha-methyl styrene (AMS), cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines. Additional end-products for intermediates include automotive components, and water treatment and pharmaceutical intermediates.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

RBC Capital Upgrades Micron Technology to Outperform with $425 Price Target

Jan 15 2026Benzinga

Micron Technology Upgrade: RBC Capital analyst Srini Pajjuri initiated coverage on Micron Technology (NASDAQ:MU) with an Outperform rating and a price target of $425, indicating significant upside from Wednesday's close of $333.35, reflecting optimism about its future performance.
BankUnited Rating Increase: Raymond James analyst Michael Rose initiated coverage on BankUnited (NYSE:BKU) with an Outperform rating and set a price target of $51, suggesting substantial upside from Wednesday's close of $45.20, demonstrating confidence in its market performance.
NVIDIA Rating Upgrade: RBC Capital analyst Srini Pajjuri initiated coverage on NVIDIA (NASDAQ:NVDA) with an Outperform rating and a price target of $240, indicating considerable upside from Wednesday's close of $183.14, signaling a positive outlook on its future growth.
LuxExperience Coverage Initiation: B. Riley Securities analyst Anna Glaessgen initiated coverage on LuxExperience (NYSE:LUXE) with a Buy rating and a price target of $12, showing clear upside potential from Wednesday's close of $8.17, reflecting an optimistic view on its market prospects.